CDIV Stock | News | Quote | Stock Forum | Sunday, October 27,

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Witch Hazel's Timeless Appeal You don’t get to celebrate over one and a half centuries of a product without doing something right. Dickinson Brands Inc. is throwing a bash worth noticing as they mark the sixth annual National Witch Hazel Day on October 21st. It’s a head-nod to the versatile witch hazel, a product that’s been part of New England's heritage since the...

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Pioneering a New Standard in Homecare Take a gander at Angels on Call Homecare. They're not just another name in a crowded field; they've carved out a niche—specializing in elite care for Dementia and Parkinson's patients. You don't usually hear homecare and innovation in the same breath, do you? But these folks are setting a fresh benchmark. Independent feedback has...

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

The Shift: From LPL to AI-Driven Innovation Hold onto your hats, because Alpha Rising Wealth Management has taken a significant leap from the traditional ship of LPL Financial to the cutting-edge shores of Rothschild Financial Partners (RFP). It's a move that's painting the walls in Scottsdale, Arizona with $250 million in client assets, all set to benefit from a modern,...

Accreditations That Matter It's not every day a treatment facility pops its head up with credentials that weigh like a ton of bricks. New Chapter Recovery in New Jersey just snagged two heavy hitters: Joint Commission accreditation and LegitScript certification. These badges don’t just glimmer for show; they’re the market's assurance against empty promises—an...

Pushing the Boundaries with AI in Drug Discovery It seems some smart folks over in South Korea are giving the pharma game a fresh twist, pitting artificial intelligence against viral invaders in a newfangled brawl. Professors from Korea University have managed to blend AI's computing prowess with good ol' lab doggedness to sniff out potential antiviral compounds. The...

FGI Industries Earnings Report Overview FGI Industries (NASDAQ: FGI) is preparing to reveal its quarterly earnings, creating anticipation among investors. Although the report was initially set for a future date, the expectation remains high for significant news regarding the company's performance and guidance. Expected Earnings and Analyst Insights Analysts project that...

Changing Priorities for US SMEs in Product Sourcing Small and medium-sized enterprises (SMEs) in the United States are gearing up for significant shifts in how they source products in the coming year. A striking 44% of these businesses are on the lookout for new suppliers, prioritizing cost efficiency and product quality above all else. This transformation is highlighted...

TD Bank's Outlook After Resolving AML Issues Scotiabank has reaffirmed its Sector Outperform rating for Toronto-Dominion Bank (TD:CN) (NYSE: TD), setting its price target at Cdn$86.00. This positive assessment comes after the resolution of TD's anti-money laundering (AML) challenges in the United States, which had raised uncertainties following the failed acquisition of...

Centene Corporation Advises Shareholders Centene Corporation (NYSE: CNC) has recently communicated important news regarding an unsolicited offer from TRC Capital Investment Corporation. TRC has proposed a 'mini-tender' offer to purchase up to 4 million shares of Centene's common stock at a price of $24.75 per share. This offer, however, is lower than the current market...

Liberty Defense Holdings Announces an Exciting New Offering Liberty Defense Holdings Ltd. (NASDAQ: LDDFF) is making waves with its announcement regarding an overnight marketed offering of units. This offering aims to finance their innovative journey in creating AI-based detection solutions for concealed weapons and potential threats in various sectors. As a key player in...